A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

Slides:



Advertisements
Similar presentations
Interdependent QSEN Competency Model
Advertisements

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
NOACs for Cancer-Associated Thrombosis:
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons From Clinical Trials.
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
The Role of Anticholinergic Therapy in Moderate to Severe Asthma
Management of Mild to Moderate Asthma
Prophylaxis Considerations for Teenagers and Young Adults With Severe Hemophilia.
Thrombosis, Cancer, and NOACs
Challenges in the Diagnosis of MS: Physician and Nurse Perspectives
Best Practices in Huntington Disease
The Patient Journey to Remission in MDD: A Collaborative Approach
The Comprehensive Major Depressive Disorder Care Team
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Medication Nonadherence in Gout
Improving Acne Outcomes
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Extended Half-life Factor Products in the Management of Hemophilia
Individualizing Prophylaxis in Hemophilia
Hot Topics in Hemophilia Nursing
Case Challenges in Chronic Migraine
The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.
Resistant Hypertension
Issues in the Management of Hemophilia: A Best Practice Series
Organizational Culture in the Oncology Medical Home
Managing IBD in Children
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams
Tailoring Hemophilia Prophylaxis Therapy
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Talking to Patients About Diabetes Management
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Team-Based Perspectives on Successful Approaches in Treating Obesity
Multidisciplinary Perspectives on Interstitial Lung Diseases
From Symptom Management to Communication in Advanced GI Cancers
Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.
Management of Adolescents With Seizures
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Managing Depression is a Team Effort:
Exploring Personalized Prophylaxis in Hemophilia A
Optimizing Outcomes and Managing Adverse Events in CLL
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
Multidisciplinary Approaches to Managing Hemophilia
Duration of Dual Antiplatelet Therapy Post-ACS: Lessons from Clinical Trials.
Prolonging the Effects of Factor IX Replacement Therapy in Hemophilia B.
Managing HF in Primary Care
Extended Half-life Factor Products in the Management of Hemophilia
Updates From the 2015 Meetings in Hemophilia
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Current Challenges in Managing Hemophilia
All for One: Multidisciplinary Management in EGFR-Mutated NSCLC
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Practical Guidance on the Management of Pan-Negative NSCLC
Etiology and Incidence Pathophysiology Hemophilia is due to a defect in thrombin generation on the platelet surface.
Communicating With Your Patients About Major Depressive Disorder
First-Line FCR: Effect of del(17p) on PFS and OS
Improving Adherence to Antiplatelet Therapy After an ACS Event
Perspective on the Multidisciplinary Management of PAH
A Multidisciplinary Perspective on the Management of Hypoparathyroidism.
Selecting Treatment Approaches in Hemophilia
The Changing Goals of CML Therapy
PAH Pathways: What Do the Data Tell Us?”
Pulmonary Arterial Hypertension and Hospitalizations
My PAH Patient.
Examining the Role of Pharmacokinetics in Hemophilia
Treatment Initiation and Selection in Newly Diagnosed CLL
Navigating the Journey
Multimodal Approaches to Cracking the Code in Low Back Pain
Presentation transcript:

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia

Program Goals

Introduction

Newly Diagnosed Hemophilia A in an Infant

Meeting Patients and Family Members “Where They Are At”

Comprehensive Care at Hemophilia Treatment Centers Multidisciplinary Care Team Members

Meeting Patients and Family Members “Where They Are At” (cont)

Source of Medical Care and Mortality

Prophylaxis and “On-Demand” Therapy Definitions

Meeting Patients and Family Members “Where They Are At” (cont)

Transitioning From Adolescence to Adulthood

Transition in the Setting of Hemophilia

Some “Red Flags” for Nonadherence to Factor Prophylaxis

Bleeds: Patient Education

Adherence to Prophylaxis Associated Factors

Meeting Patients and Family Members “Where They Are At” (cont)

Conclusions

Abbreviations

References

References (cont)

References (cont)